Summary mRNA for the suppressive epitope of plSE was found to be present in 24 of 30 samples of human colorectal cancer and in all four specimens of gastric cancer. mRNA for p1SE was seldom seen in nonmalignant colonic or gastric mucosa but, when present, was associated with inflammatory or pre-malignant conditions of the digestive tract. Synthetic peptides derived from the conserved plSE sequence were found to suppress some aspects of the immune response implicated in anti-tumour activity. These data suggest that a plSE-related material with immunomodulatory properties is elaborated within human tumours, either by the tumour itself or as a normal component of the endogenous anti-tumour reaction.
Summary mRNA for the suppressive epitope of plSE was found to be present in 24 of 30 samples of human colorectal cancer and in all four specimens of gastric cancer. mRNA for p1SE was seldom seen in nonmalignant colonic or gastric mucosa but, when present, was associated with inflammatory or pre-malignant conditions of the digestive tract. Synthetic peptides derived from the conserved plSE sequence were found to suppress some aspects of the immune response implicated in anti-tumour activity. These data suggest that a plSE-related material with immunomodulatory properties is elaborated within human tumours, either by the tumour itself or as a normal component of the endogenous anti-tumour reaction.
In vitro, combination of cytokines and cytotoxic cell precursors result in the generation of a variety of effector cell functions with anti-tumour activity. Unfortunately the in vivo clinical application of these concepts in humans suffering from malignant disease has met with only limited success, and this only in patients with selected tumours such as malignant melanoma and renal cell cancer (West et al., 1987; Rosenberg et al., 1989; Guillou, 1991) . Explanations for this are manifold but one possibility which we, and others, have focused upon in recent years is that tumours may be able to subvert any useful immunologically based endogenous antitumour reaction by the elaboration of soluble moieties which possess immunosuppressive properties (Ebert et al., 1987; Guillou et al., 1989a, b; Somers et al., 1991) .
A variety of murine and human tumours have been found to exert immunosuppressive effects in vitro. Some studies have associated these effects with the presence of the retroviral envelope protein pl5E . pl5E is encoded by the env gene of the murine and feline leukaemia viruses. There is 73% homology in a 26-amino acid stretch between p1SE and gp2l of the human T-cell leukaemia viruses HTLV-1 and HTLV-2. This 26-amino acid sequence contains a string of 17 amino acids (Table I) which has previously been discovered in the murine B16 melanoma (Leong et al., 1988) and in human head and neck cancers (Tan et al., 1987) . Synthetic peptides of this 17-amino acid string can impair a number of lymphocyte-and monocytemediated reactions both in vivo (Nelson et al., 1989) and in vitro (Harrell et al., 1986; Oostendorp et al., 1992) . Such peptides have also been reported to inhibit the production of interleukin-2 (IL-2) (Nelson & Nelson, 1990 ) a defect which is common in patients suffering from advanced cancer (Monson et al., 1986) .
In this study we aimed to determine whether or not pl5E-related material might explain the in vivo and in vitro immunosuppression seen in patients with colorectal and gastric tumours (Monson et al., 1987; Guillou, 1989 
Materials and methods
RNA preparation and analysis Samples of tumour were obtained from 31 patients undergoing colorectal resection for a diagnosis of colorectal cancer. Of these the diagnosis was histologically substantiated in 30 patients, the remaining diagnosis being that of a stricture of the ascending colon due to Crohn's disease. This latter resection was performed on the radiological presumption that the stricture was a carcinoma so the data obtained for this specimen are also presented. Tumour samples were also obtained from fresh operative gastrectomy specimens during resectional surgery in four patients suffering from endoscopically and biopsy-proven carcinoma of the stomach. The demographic and pathological staging data on the patients with colorectal and gastric cancer are shown in Table II . Simultaneously with the acquisition of the tumour samples, whenever possible, samples of normal colonic or gastric mucosa were removed from the proximal resection margin, at least 10 cms from the tumour. The samples were obtained fresh from the operating room, freed of debris, snap-frozen in liquid nitrogen within 10 min of surgical removal, and stored at -70'C until RNA extraction.
Total cellular RNA was prepared using the RNAzol B method (Biogenesis, Bournemouth, UK). Briefly, the tissue was homogenised in RNAzol followed by extraction of the RNA in chloroform and precipitation in isopropanol. The (Sigma) ). Hybridisation was conducted overnight at 57°C using 3'-end 32P-labelled oligonucleotide probes (British Biotechnology, Oxford, UK). The specific probe for plSE-related material corresponded to the 10 amino acid sequence common to both pl5E and gp2l of HTLV (Table I ). The sequence of this probe was as follows:
S'-GAA TAG AAT ATC TAG GCC CCG TCT GTT TGG-3' Two controls for the pl5E probe, one with a three nucleotide substitution and one with a six nucleotide substitution, were also prepared. These control probes did not cross hybridise with the p15E probe under the hybridisation conditions used. Simultaneous controls for the RNA extraction procedure were also run using standard P-actin probes (British Biotechnology, Oxford, UK). After hybridisation the membranes were washed for 10 min at room temperature in 2 x SSC and 0.2% SDS followed by two washes for 40 min at 57°C in 0.1 x SSC and 0.2% SDS. Membranes were autoradiographed with Fuji RX X-ray film (Wardray Ltd., Surrey, UK) at -70°C.
Synthetic peptides
Peptides derived from the conserved p1SE sequence (Table I) were synthesised by a standard technique on an Applied Biosystems 431A peptide synthesizer (Foster City, CA, USA) and cleaved in trifluoroacetic acid/5% phenol. The crude peptides were purified by gel filtration and reverse-phase chromatography and lyophilised from 20% acetic acid. Purity was assessed by amino acid analysis and reverse-phase chromatography to be greater than 95%. The amino-acid sequences of the peptides used in these experiments were as follows:
Peptide FG-17: LQNRRGLDLLFLKEGGL Peptide FG-10: QNRRGLDLLF The 10-amino acid sequence is a component of the 17-amino acid immunosuppressive peptide of retroviral p1SE. This peptide has been extensively characterised as CKS-17 . The studies quoted used multiple modifications of the 17-amino acid sequence, none of which exhibited immunosuppressive activity. We therefore did not repeat these experiments here. For the purposes of the present experiments, the peptides were not coupled to human serum albumin and were dissolved in culture medium directly for in vitro use. The influence of synthetic peptides on the induction of lymphokine-activated killer (LAK) cells was examined in bulk cultures of PBMC containing 2 x 106 cells per ml in TCM in 6-well plates containing 8 x 106 cells. These were activated by adding 1,000 units mll recombinant human IL-2. FG-10 and FG-17 were added at a final concentration of 10-6 M. To some wells no peptides were added, partly to act as controls and partly to provide LAK cells for studies of the potential influence of these peptides on the cytotoxicity assay. These bulk cultures were incubated for 4 days at 37°C and then harvested for use as effector cells in the cytotoxicity assay. This was performed as previously described . Briefly, 3 x 106 COLO 320 target cells were labelled with 100IfCi of 51Cr-Na2CrO4 (ICN-Flow) for 1 h.
After washing in phosphate buffered saline 104 51Cr-labelled target cells in 100 ;Ll TCM were added to the wells of 96-well plates. One hundred effector cells from the bulk cultures were also added to these wells in triplicate at effector:target cell ratios ranging from 100:1 down to 3:1. The percentage specific 5'Cr-release at each effector:target cell ratio was then calculated according to the formula:
Specific 5'Cr release= Experimental -Spontaneous release x 100% Maximal -Spontaneous release where spontaneous release is that from wells to which no effector cells have been added and maximum release was that observed when the effector cells were replaced by a detergent solution. The data are expressed as Area Under the Curve (AUC) units as previously described in detail .
Immunoglobulin production PBMC isolated as described above were cultured as for the proliferation assays but instead of IL-2 or anti-CD3 antibody, 10 jig ml' of Pokeweed mitogen (Sigma) was added.
Peptides at the concentrations described were added to these cultures, control wells containing no peptide. The plates were incubated at 37°C for 10 days following which 100 l1 supernatant were harvested from each well and the total immunoglobulin content of the supernatant measured using an ELISA technique. Briefly, a 96-well Immunoplate (ICNFlow) was coated with goat anti-human polyvalent immunoglobulin (Sigma) in a carbonate-bicarbonate buffer overnight at 4°C. The wells were washed with a washing solution (1% Tween (Sigma) in PBS) three times and blocked with 1% bovine serum albumin (Sigma) in PBS for 1 h at 37°C. The blocking solution was aspirated from the wells and the test supernatants added. The plate was incubated for 1 h at 37°C and washed three times with washing solution. Alkaline phosphatase conjugated goat anti-human polyvalent immunoglobulin (Sigma) was then added to the wells and incubated at 37°C for 1 h, washed three times, and alkaline phosphatase substrate (Sigma) added to the wells. The substrate was allowed to develop colour for 30 min and the reaction was then stopped using IN Sulphuric Acid. The absorbence was measured on a Titertek Multiscan ELISA reader (ICN-Flow) using a 405 nm filter and the data analysed using Titersoft Software (ICN-Flow).
Neutrophil oxidative burst Peripheral blood granulocytes isolated from healthy donors as described above were incubated either alone or with FG-10 or FG-17 for 2 h at 37°C and their oxidative burst in response to activation with Zymosan or Phorbol-Myristic Acetate (PMA) was measured using a modification of a previously described technique (Bass et al., 1986; Wakefield et al., 1993) . Briefly, 1.5 x 106 granulocytes ml-I were incubated in 5 mM 2,7-Dichlorofluorescein diacetate (Eastman Kodak ) for 15 min at 37TC. One ml aliquots of this suspension were then added either to 1 ml of Dulbecco's phosphatebuffered saline containing glucose and gelatine (DPBS-G), or DBPS-G containing 200 ng ml-' PMA or DPBS-G containing zymosan. The intensity of neutrophil fluorescence was measured by flow cytometry at 45 min. The data acquired for granulocytes incubated with the peptides were compared with those granulocytes to which no peptide had been added. Hybridisation analysis of human endogenous piSE-related transcripts Northern blot analyses for plSE-related mRNA were performed on 30 individual samples of colorectal cancer, one sample of colonic mucosa subsequently shown to be afflicted by Crohn's disease, and 24 samples of macroscopically 'normal' colonic mucosa from 24 of the colorectal cancer resectional specimens. Of these, positive blots for plSE-related mRNA were identified in 24 of the colorectal cancer specimens whereas positive blots were obtained for only four of the 24 specimen of 'normal' colonic mucosa from the same patients. (pl5E-related positivity in cancer tissue vs that in 'normal' mucosa, d.f. = 1, x2 = 21.4, P<0.001). Typical examples of plSE-related positive samples of colorectal cancer, together with negative blots from the correspondingly macroscopically 'normal' mucosa are shown in Figure 1 . There was no statistically significant relationship between the incidence of p1SE-related positivity to the stage of progression of the colorectal cancer as determined by Dukes' classification (Table III) . The specimen of tissue obtained from the single patient who histologically was found to have Crohn's disease was also positive for plSE-related mRNA. Interestingly, of the four macroscopically 'normal' samples of mucosa which were positive for pl5E-related mRNA, one was histologically found to be suffering from non-specific ulcerative colitis and two were afflicted by multiple polyps (of the non-familial type). The remaining positive sample was histologically normal as were all the other samples of macroscopically normal, pl5E-related negative colonic mucosa.
All four samples of gastric carcinoma tissue were positive for p1SE mRNA on Northern blotting. Of the four corresponding samples of macroscopically normal gastric mucosa, only one was found to be positive and three negative. These three samples were histologically normal but the sample of positive 'normal' mucosa was the site of an active chronic gastritis with metaplasia.
Effects of FG-JO and FG-17 on lymphocyte proliferation
Both the FG-10 and FG-17 peptides produced inhibition of the two-way MLR but this did not reach statistical signi- ficance until the concentrations of the peptides were 10-M in culture (P<0.01, Student's t-test) (Figure 2) . The concentration of these two peptides required to induce statistically significant (P<0.01) suppression of the proliferative response to recombinant IL-2 was also 10-6M (Figure 3 ). In contrast, both peptides consistently (P<0.01) inhibited anti-CD3-induced lymphocyte proliferation at concentrations of 10-9M or more (Figure 4 ).
Effects of FG-10 and FG-17 on polyclonal B-cell activation Neither of the two synthetic peptides cause any detectable inhibition of immunoglobulin production in response to polyclonal activation with pokeweed mitogen. Indeed, at a concentration of 10-6 M peptides the amount of immunoglobulin present in the supernatants of these polyclonally activated B-cells was slightly but significantly elevated (P<0.05, Figure 5 ).
Effects of FG-10 and FG-17 on the generation of lymphokineactivated killer (LAK) cells As can be seen from the data shown in Figure 6 , under the conditions utilised in these experiments no inhibition of either LAK cell generation or the lytic efficacy of unmodified LAK cells was observed. Effects of FG-10 and FG-17 on the neutrophil oxidative burst Both peptides at a concentration of 10-6 M significantly suppressed the basal, zymosan-activated and PMA-activated neutrophil oxidative burst (P<0.05, Student's t-test ( Figure  7) ). E on basal, zymosan-induced and PMA-induced neutrophil oxidative burst. Vertical bars denote mean ± standard error of mean channel fluorescence obtained for the three separate experiments (*P <0.05).
Discussion
Our experiments have revealed that the majority of human colorectal and some gastric cancers contain cells which express RNA for a highly conserved retroviral sequence which is known to possess immunosuppressive properties Harrell et al., 1986; Ogasawara et al., 1988) . The size range of this sequence is consistent with that reported for other endogenous retroviral products (Repaske et al., 1985) .
In the colon the majority of the macroscopically normal samples of mucosa failed to express plSE-relative mRNA. Of the five samples of non-malignant colorectal mucosa which were positive for plSE-related expression, four were histologically abnormal, two being afflicted with inflammatory bowel disease and two contained non-familial multiple polyps. A similar pattern was obtained for the small number of tissues obtained from the gastric cancer resectional specimens with all the tumours being positive for pl5E-related mRNA, the only macroscopically normal positive mucosa being the seat of a severe chronic active gastritis with metaplasia.
The observations invite questions concerning the origin of the pl SE-related mRNA seen in these tumours. Certainly plSE-related protein has been described in certain human tumour cells and rodent tumour cell lines (Cianciolo et al., 1983; . In addition sera from patients with certain haematopoietic malignancies contain a 74-kDa glycoprotein which contains a plSE-related epitope again suggesting that certain tumours of non-viral origin do express plSE-like material (Jacquemin & Strijckmans, 1985) . The possibility that this material is expressed early during tumorigenesis might explain the fact that mRNA for this protein was observed in five out of six samples of non-malignant gastrointestinal mucosa, these five being histologically afflicted by conditions known to be pre-malignant viz. inflammatory bowel disease, colonic polyps, and gastritis with metaplasia. On the other hand, it could be argued that the positive isolates from the 'non-malignant' mucosae were due to contamination by tumour cells in all but one instance (the colon affected by Crohn's disease rather than malignant disease), since both the malignant and non-malignant samples were obtained from the same surgical specimens. However, we endeavoured to minimise this possibility by removing the 'normal' intestinal mucosa at a site at least 10 cm from a proximal site, away from the faecal stream.
An equally likely source for the p15E-like mRNA in these tissue samples is of course the inflammatory cells which they contain. It has been previously reported that murine monoclonal antibodies raised against an identical (but BSA-conjugated), peptide to , have identified such material in inflamed lymphoid tissue (Tas et al., 1991) and in malignant and chronic inflammatory conditions of the nasooro-pharynx (Tan et al., 1987; Scheeren et al., 1992) . The latter study by Scheeren et al. (1992) is of particular interest in that these authors were also unable to identify plSE-like material in normal intestinal mucosa using the 4F5 and 19F8 monoclonal antibodies described by Cianciolo et al. (1983) .
Antibodies to the CD4 epitope on human lymphocytes also bind to CKS-17 (Rothman et al., 1990) , but as yet there is no data which suggest that the antibodies to CKS-17 can bind to the CD4 molecule (Table I) . However, only a small proportion of the inflammatory cell infiltrate in colorectal cancer is known to be CD4-positive, the majority being CD14-positive monocytes (Allen & Hogg, 1987) . However, this latter observation presents us with further alternatives for CKS-17 antibody binding partners.
A 10-amino acid sequence from interferon-a (INF-a) has been identified which has a high level of sequence homology with CKS-17 (Table I ) (Ruegg & Strand, 1990 ). This appears to be the smallest biologically active sequence of INF-a and has similar immunosuppressive properties to those which we describe here for our own synthetic peptides. CD14-positive monocytes are a potent source of INF-a. Using a computerised homology search we have found that there is a sequence identity between our 10 amino acid peptide and a sequence in tumour necrosis factor-a (TNF-x) (Table I) .
Again monocytes are a major cell of origin of TNF-x which has also been found to be present in colorectal cancer (Beissert et al., 1989) . However, these alternative proteins which may cross-react with CKS-17 specific antibodies have sufficiently different mRNA nucleotide sequences from pI 5E that they are very unlikely to hybridise with our oligonucleotide probe under the hybridisation conditions employed.
Although we demonstrated the presence of plSE-related mRNA at the site of colorectal and gastric cancers and in some inflamed and pre-malignant sites in these organs, the role of the proteins encoded by this endogenous message in humans is unknown. To investigate this we therefore constructed two synthetic peptides, FG-10 and FG-17 (Table I) which correspond to the endogenous p1 5E nucleotide sequence. At a concentration of 106 M both these peptides inhibited lymphocyte proliferation in mixed lymphocyte culture and in response to IL-2. Since the immunosuppressive properties of FG-10 and FG-17 did not differ, the active component must residue within the shorter ten amino acid sequence. By means of peptide screening of uncoupled peptides, Oostendorp et al. (1992) have recently described the antilymphoproliferative properties of a LDLLFL sequence which is fully contained in our FG-17 peptide but is only partially represented in the FG-10 peptide. Suppression of IL-2-induced proliferation occurred at identical concentrations in culture to those seen with our own peptides. However, in our studies the inhibition of anti-CD3-induced T-cell proliferation occurred at lower concentrations than those required to inhibit the MLR or IL-2 induced lymphocyte proliferation, suggesting that these peptides may specifically suppress T-cell function through the CD3-T cell receptor complex. These peptides also inhibit the neutrophil oxidative burst. The fact that intracellular signalling for PMA-stimulated oxidative burst is mediated via protein phosphokinase C whereas that for T-cell proliferation is via the phosphatidylinositol 4,5-biphosphate hydrolysis pathway suggests that these peptides possess multiple mechanisms of action.
Like the fusion proteins of HIV-1, these peptides may readily insert into the lipid bilayer of the cell membrane and interfere with a variety of ligand-induced signals. In contrast the lack of activity of these peptides on LAK cell induction or PWMinduced polyclonal immunoglobulin production suggests that their mode of action may be more specific than appears at first sight. It is also intriguing that our peptides exert their immunosuppressive activities without having to be conjugated to a carrier protein as was necessary for CKS-17 (Har-rell et al., 1986; Ogasawara et al., 1988; Nelson et al., 1989; Nelson & Nelson, 1990) . As yet we are unable to explain this discrepancy. Repaske et al. (1985) have described a full length endogenous human retroviral DNA which includes the code for a ten amino acid sequence (Table I) simliar to the FG-10 sequence. Whether or not this sequence codes for a peptide which possesses the same properties as FG-10 remains to be investigated and raises the question of the function of such sequences within the human genome. It is presumed that endogenous pl5E-like proteins serve a useful purpose in regulating the cellular immune response. In the murine system p1SE has been shown to be an important component of the inhibitory feedback circuit whose expression is induced not only by immune stimuli but also by glucocorticoids (Krieg et al., 1989; Helmberg et al., 1990) . Since these sequences are highly conserved amongst the murine, feline and human species it is not unreasonable to suppose that these events are common to all the species.
We have made the assumption that the amino acid sequence constituting FG-10 is a functional component of a protein with the same functional attributes which are not lost during tertiary processing. Thus it might be argued that if the specific mRNA is of leukocyte origin, these data do provide evidence of the activation of an immune response against the tumour within the primary site, the presence of pl5E-related mRNA representing the negative feedback regulatory arc of such a response. We are currently attempting to identify the presence of pl5E-related mRNA in in vivo activated human lymph nodes in an attempt to provide evidence for or against this hypothesis. Conversely, the interaction of tumour cells with the infiltrating inflammatory cells may cause the tumour cells to produce immunoregulatory proteins, some of which may provide a survival advantage for the tumour cells. The outcome of this teleological argument must await the isolation of the protein that is translated by the mRNA that our oligonucleotide probes have identified and also immunohistochemical studies of the expression and distribution of such proteins using monoclonal antibodies which we are currently developing for this purpose. However, as has been suggested by others (Nelson et al., 1985; Lindvall et al., 1991) , such reagents may also become important therapeutic tools as adjuncts to tumour immunotherapy in addition to providing scientific explanations for the failure of immunotherapy in so many instances.
